Adenosine A2A Receptor Antagonists as Positron Emission Tomography (PET) Tracers

被引：0

作者：

Khanapur, S. ^{[1
]}

van Waarde, A. ^{[1
]}

Ishiwata, K. ^{[2
]}

Leenders, K. L. ^{[4
]}

Dierckx, R. A. J. O. ^{[1
,3
]}

Elsinga, P. H. ^{[1
,3
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands

[2] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Tokyo, Japan

[3] Univ Hosp Ghent, Dept Nucl Med, Ghent, Belgium

[4] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 GZ Groningen, Netherlands

来源：

CURRENT MEDICINAL CHEMISTRY | 2014年 / 21卷 / 03期

关键词：

Adenosine A(2A) receptor; Parkinson's disorder; positron emission tomography (PET); xanthine ligands; nonxanthine; ligands; SCH442416; TMSX; 6-OHDA PD model; MOVEMENT-DISORDER SOCIETY; CENTRAL-NERVOUS-SYSTEM; JOINT TASK-FORCE; PARKINSONS-DISEASE; THERAPEUTIC MANAGEMENT; PIPERAZINE DERIVATIVES; NEUROLOGICAL SOCIETIES; MEDICINAL CHEMISTRY; EUROPEAN FEDERATION; SELECTIVE LIGAND;

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The adenosine A(2A) receptor (A(2A)R) is highly concentrated in the striatum, and a therapeutic target for Parkinson's disorder (PD) and Huntington's disease. High affinity and selective radiolabeled A(2A)R antagonists can be important research and diagnostic tools for PD. Positron Emission Tomography (PET) can play an important role by measuring radiolabeled A(2A) antagonists non-invasively in the brain. However, till date no complete review on A(2A)R PET ligands is available. The present article has been therefore focused on available PET tracers for A(2A)R and their detailed biological evaluation in rodents, nonhuman primates and humans. Drug design and development by molecular modeling including new lead structures that are potential candidates for radiolabeling and mapping of cerebral A(2A)Rs is discussed in the present article. A brief overview of functions of adenosine in health and disease, including the relevance of A(2A)R for PD has also been presented.

引用

页码：312 / 328

页数：17

共 118 条

[1] 7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists:: A study on the importance of modifications at the side chain on the activity and solubility [J].

Baraldi, PG ;

Cacciari, B ;

Romagnoli, R ;

Spalluto, G ;

Monopoli, A ;

Ongini, E ;

Varani, K ;

Borea, PA .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (01) :115-126

[2] Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists [J].

Baraldi, PG ;

Cacciari, B ;

Spalluto, G ;

Bergonzoni, M ;

Dionisotti, S ;

Ongini, E ;

Varani, K ;

Borea, PA .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) :2126-2133

[3] Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: Potent and selective A(2A) adenosine antagonists [J].

Baraldi, PG ;

Cacciari, B ;

Spalluto, G ;

Villatoro, MJPDIY ;

Zocchi, C ;

Dionisotti, S ;

Ongini, E .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (05) :1164-1171

[4] Adenosine receptor antagonists: Translating medicinal chemistry and pharmacology into clinical utility [J].

Baraldi, Pier Giovanni ;

Tabrizi, Mojgan Aghazadeh ;

Gessi, Stefania ;

Borea, Pier Andrea .

CHEMICAL REVIEWS, 2008, 108 (01) :238-263

[5]

Bauer Andreas, 2009, Handb Exp Pharmacol, P617, DOI 10.1007/978-3-540-89615-9_19

[6] Striatal adenosine A2A receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [18F]-MRS5425 [J].

Bhattacharjee, Abesh Kumar ;

Lang, Lixin ;

Jacobson, Orit ;

Shinkre, Bidhan ;

Ma, Ying ;

Niu, Gang ;

Trenkle, William C. ;

Jacobson, Kenneth A. ;

Chen, Xiaoyuan ;

Kiesewetter, Dale O. .

NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (06) :897-906

[7] Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain [J].

Brooks, D. J. ;

Doder, M. ;

Osman, S. ;

Luthra, S. K. ;

Hirani, E. ;

Hume, S. ;

Kase, H. ;

Kilborn, J. ;

Martindill, S. ;

Mori, A. .

SYNAPSE, 2008, 62 (09) :671-681

[8] An Open-Label, Positron Emission Tomography Study to Assess Adenosine A2A Brain Receptor Occupancy of Vipadenant (BIIB014) at Steady-State Levels in Healthy Male Volunteers [J].

Brooks, David J. ;

Papapetropoulos, Spyridon ;

Vandenhende, Francois ;

Tomic, Davorka ;

He, Ping ;

Coppell, Alex ;

O'Neill, Gilmore .

CLINICAL NEUROPHARMACOLOGY, 2010, 33 (02) :55-60

[9] Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease [J].

Brooks, DJ .

JOURNAL OF NEUROLOGY, 2000, 247 (Suppl 2) :11-18

[10] Synthesis and pharmacology of pyrido[2,3-d]pyrimidinediones bearing polar substituents as adenosine receptor antagonists [J].

Bulicz, J ;

Bertarelli, DCG ;

Baumert, D ;

Fülle, F ;

Müller, CE ;

Heber, D .

BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (08) :2837-2849

← 1 2 3 4 5 6 7 8 9 10 →